| Miss Belinda Aristud-santiago, CRNA, MSN | |
|
B & C Anesthesia- Pavia Hospital, Calle Profesor Augusto Rodriguez #1462, Santurce, PR 00910-0000 | |
| (787) 641-1616 | |
| Not Available |
| Full Name | Miss Belinda Aristud-santiago |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | B & C Anesthesia- Pavia Hospital, Santurce, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508004417 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 074654 (Puerto Rico) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 1311 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Belinda Aristud-santiago, CRNA, MSN Po Box 286, Trujillo Alto, PR 00977-0286 Ph: (787) 310-6870 | Miss Belinda Aristud-santiago, CRNA, MSN B & C Anesthesia- Pavia Hospital, Calle Profesor Augusto Rodriguez #1462, Santurce, PR 00910-0000 Ph: (787) 641-1616 |
News Archive
Skatchewan is a vast prairie province in the middle of Canada. It's home to hockey great Gordie Howe and the world's first curling museum. But Canadians know it for another reason: it's the birthplace of the country's single-payer health-care system.
They found that the anti-cancer drug imatinib mesylate — commercially known as Gleevec and produced by Novartis Pharmaceuticals — can target a gene critical to controlling the disease process. Previously, there had been no treatment and patients usually did not survive beyond three years of diagnosis. Now the treatment is undergoing clinical trials at Mayo Clinic.
Gilead Sciences, Inc. announced today its results of operations for the quarter ended June 30, 2012.
This risky method of anti-cancer therapy was suggested by scientists of Far Eastern Federal University (FEFU). Their review of mechanisms for molecular activation of stem cells of gliomas (most widely-spread brain tumors) was approved for publishing in the Frontiers in Cellular Neuroscience journal.
› Verified 4 days ago